SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-17-008889
Filing Date
2017-11-14
Accepted
2017-11-14 08:13:17
Documents
68
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 6-K sbbp-20170930x6k.htm 6-K 1511708
2 EX-10.21 sbbp-20170930ex1021e33ec.htm EX-10.21 128181
3 EX-10.6 sbbp-20170930ex1067f35d6.htm EX-10.6 149694
4 EX-10.7 sbbp-20170930ex10730aa02.htm EX-10.7 108695
  Complete submission text file 0001558370-17-008889.txt   5858174

Data Files

Seq Description Document Type Size
5 EX-101.INS sbbp-20170930.xml EX-101.INS 1030976
6 EX-101.SCH sbbp-20170930.xsd EX-101.SCH 46819
7 EX-101.CAL sbbp-20170930_cal.xml EX-101.CAL 50937
8 EX-101.DEF sbbp-20170930_def.xml EX-101.DEF 165898
9 EX-101.LAB sbbp-20170930_lab.xml EX-101.LAB 409814
10 EX-101.PRE sbbp-20170930_pre.xml EX-101.PRE 315485
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 6-K | Act: 34 | File No.: 001-37569 | Film No.: 171198415
SIC: 2834 Pharmaceutical Preparations